- Home
- DVS vs ABSI Comparison
DVS vs ABSI Comparison
Compare DVS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DVS | ABSI |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 446.5M | 357.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DVS | ABSI |
|---|---|---|
| Price | $4.58 | $2.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.48 | $2.01 |
| 52 Week High | $5.93 | $5.23 |
Technical Indicators
Market Signals| Indicator | DVS | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 44.22 |
| Support Level | $4.28 | $2.49 |
| Resistance Level | $5.04 | $2.88 |
| Average True Range (ATR) | 0.26 | 0.16 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 41.74 | 44.44 |
Price Performance
Historical ComparisonAbout DVS Dolly Varden Silver Corporation
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.